Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of XenoTherapeutics.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
XenoTherapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
359 Newbury Street, 5th Floor Suite 526 Boston, MA 02115 ​
Telephone
Telephone
617-939-7892 ​
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

XenoTherapeutics has completed the first of two patient cohorts in the company’s Phase I trial of Xeno-Skin™, first-in-human, live-cell xenotransplant to treat severe and extensive burn wounds. As a result, the U.S. FDA has agreed to permit accelerated patient enrollment.


Lead Product(s): Xeno-Skin

Therapeutic Area: Trauma (Emergency, Injury, Surgery) Product Name: Xeno-Skin

Highest Development Status: Phase IProduct Type: Cell and Gene therapy

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable November 05, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY